chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On 21-AUG-2014 the patient was vaccinated with M-M-R II (Batch/lot # H014989, expiration date: 10-AUG-2014) 0.5 ml, subcutaneous after the labeled expiration date. No adverse events were reported. Additional information has been requested.
Mom reports child developed a rash "head to toe" about 4 days after receiving vaccines. Had a low temperature but none since. Does not act if it itches her or makes her uncomfortable. No treatments at this time.
dizziness while lying in bed after turning over onto her back/ dizziness when standing up quick, turning over onto her back or side while in bed, and getting out of her car; had been a few times while lying in bed that her vision was affected when this dizziness comes on; This is a spontaneous report from a contactable consumer (reported for herself). A 56-year-old female patient (not pregnant at the time of vaccination) received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EK9231), via an unspecified route of administration on 07Jan2021 15:00 at single dose in right arm for COVID-19 immunization. Medical history included Hypothyroidism, No Allergies to medications, food, or other products. Concomitant medication received within 2 weeks of vaccination included levothyroxine. Facility where the most recent COVID-19 vaccine was administered in Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Vaccine was given on a Thursday afternoon, on Saturday morning, the patient experienced a dizziness while lying in bed after turning over onto her back. She only experienced the dizziness when standing up quick, turning over onto her back or side while in bed, and getting out of her car. She had never had any trouble with dizziness. There had been a few times while lying in bed that her vision was affected when this dizziness comes on. To date she was still having problems. The events started on 09Jan2021 06:30. No any treatment received for the adverse events. The events were non-serious per the reporter. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The outcome of the events was not recovered.
tingly (tightness) ) on right face cheek area, forehead (right side), down cheek to the right side of upper and lower lips and felt it toward right ear. Everything was on right side of face; This is a spontaneous report from a contactable consumer. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 01Apr2021 at 14:45 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included alpha1 carrier and migraine. It was unsure if the patient had any allergies. Concomitant medications included sumatriptan succinate (SUMATRIPTAN) indicated for migraines, multi vitamin and other unspecified medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 (also reported 02:45), the patient experienced tingly (tightness) on right face cheek area, then it went to forehead (right side), then it went down her cheek to the right side of her upper and lower lips and she also felt it towards her right ear. Everything was on the right side of face, almost exactly separated at the very center of the face. Therapeutic measure was taken as a result of event tingly and included treatment with benedryl. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tingling was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This is a spontaneous report from a contactable consumer reporting for herself from a Pfizer-sponsored program. A 63-year-old female patient received the 1st dose of PREVNAR 13 via an unspecified route of administration at single dose on an unspecified date for pneumonia, immunisation. Medical history included: in 2009, she was diagnosed with post inflammatory fibrosis because of all the scar tissue in her lungs from the double pneumonia), pneumonia 2 years before (she got the shot for pneumonia), chronic obstructive pulmonary disease, chills, then fever, sweat, and chills hit me out of nowhere, pyrexia, her boyfriend broke into her house and called an ambulance when he found her unconscious, they took her to the hospital where she was given 48 hours to live, but was in a coma for a month and a half, she still struggle with short term memory loss. The patient's concomitant medications were not reported. The patient was feeling sick requiring hospitalization on an unspecified date. It was further reported that two years before this report, she got the shot for pneumonia. Then last year, her grandson visited. And she told them not to bring him if he was sick. He was fine during the day, but then he spent all Saturday night coughing on me. On Sunday, she felt ok while she ran errands, but by evening she was feeling sick. On Monday, she went to the hospital where she stayed for 4 days. The outcome of the event was unknown. Information on the batch number has been requested.
Patient presented to pharmacy to receive a Shingles Vaccine. Patient instead received a the Pfizer Covid-19 vaccine. Patient has previously complete the Moderna Covid-19 vaccine in February.  We will follow up with the patient.
Shot administered at 12:05. This was patient second dose. Pt did not report any side affects with first dose. At approximately 12:12 pt began coughing. Pt given water. At 12:15 pt stated "I feel like something is in my throat".  Bp 142/84, HR 108, O2 sats 99%. EMS called and pt transferred to hospital at 12:55.  HR and O2 sats remained unchanged until EMS arrived.
1.  Woke up following morning , I had difficulty urinating. 2.  99.3 fever the following day around 4 pm.  Took 2 tablets of tylenol. 3.  Fever gone after a few hours. 4.   Still had difficulty urinating whole day up to evening of the 2nd day.
rash, fever, edema adm to hosp;given med d/c 1 day & resolved;
the patient did not receive the full 0.3 mL dose of the Pfizer COVID-19 vaccine; when the nurse, administering the vaccine, withdraw the needle from her daughter's arm, fluid, in which caller believes was the vaccine, leaked from the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administration date 10Mar2021 (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: UNDERDOSE (non-serious) with onset 10Mar2021, outcome "unknown", described as "the patient did not receive the full 0.3 mL dose of the Pfizer COVID-19 vaccine"; INJECTION SITE EXTRAVASATION (non-serious) with onset 10Mar2021, outcome "unknown", described as "when the nurse, administering the vaccine, withdraw the needle from her daughter's arm, fluid, in which caller believes was the vaccine, leaked from the injection site".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Baby expired around 6AM on 10-21-11 as per the grandmother's call to the office at 0900 (approx).
I experienced this rather immediate unexpected gradually increasing dizziness with impaired balance while walking at accustomed pace over approximately 12-15 minute time period.  I was compelled to leave the track and lay down on an exercise mat where fortunately my wife came by t Within half hour of this attack i coiuld not stand and walk independently without support. My first time to a hospital ER  in my 78 years of life. Recommended for observation and additional tests I stay overnight in observation unit. Diagnosis appeared to be perplexing for physicians.  My wife  came by to assist me in standing , walking to the car and driving me to nearby ER. What happened to me was a frightening, anxiety-producing and dangerous situation. I could have easily fallen with substantial head or other bodily injury. Being in excellent health and with nothing else unusual having occurred recently to affect my general health (no changes, no illnesses), I cannot help conclude this episode was a serious adverse reaction to my 2nd Moderna vaccination.  I now consider what happened on 3/28/21 a "Vestibular Attack". I think possibly my body for some reason related to the vaccine might have been attacking itself, if that makes sense to scientists.  I hope this doesn't happen to others. I am not anti-vaccination. But individuals should be warned about this possible dangerous reaction or adverse side effect, which in my case did not occur immediately after the 2nd Moderna dose. I've complained to the hospital that possibility of severe dizziness with extreme loss of balance being related to recent Moderna 2nd vaccination was NOT discussed or commented.
Exposure to COVID-19 virus Office Visit 3/18/2021 - 72 y.o. Female; born Jun. 26, 1948June 26, 1948Encounter Summary, generated on May 13, 2021May 13, 2021  Reason for Referral  Diagnostic Imaging (Routine) Diagnostic Imaging (Routine) Status Reason Specialty Diagnoses / Procedures Referred By Contact Referred To Contact Closed   Radiology Diagnoses   COVID-19 virus infection   Cough     Procedures   Chest PA and Lat today    Electronically signed byMD at    Reason for Visit  Reason Comments Cough Cough and fever, positive for Covid 3-8-21
UNSPECIFIED REACTION; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight was 55.9 kilograms, and height was not reported. The patient's concurrent conditions included primary pulmonary hypertension. The patient received iloprost (inhalation vapour, solution, route of admin not reported, batch number: MA03S04 expiry: 31-AUG-2024) 5 ug, frequency, and therapy dates were not reported for primary pulmonary hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. Batch number was not reported. The company is unable to perform follow up to request batch/lot numbers. Concomitant medications included bosentan for primary pulmonary hypertension, and tadalafil. On an unspecified date, the subject experienced unspecified reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and treatment with iloprost was withdrawn. The outcome of unspecified reaction was not reported. This report was non-serious.
Having a reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Having a reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Having a reaction). At the time of the report, VACCINATION COMPLICATION (Having a reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment medications were provided by the reporter.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 05-MAY-2014, the patient was vaccinated with one dose of RECOMBIVAX HB (dose, strength, lot number and expiration date were not reported) intramuscular route. Co-suspect and concomitant therapies were not reported. The healthcare worker reports that an improperly stored RECOMBIVAX HB was administered on 05-MAY-2014. The healthcare worker reports that the RECOMBIVAX HB was exposed to a temperature of 34F for 30 minutes on 05-MAY-2014. No adverse effect reported. Additional information has been requested. There case is one (1) of ten (10) reports from the same reporter. (MARRS 1405USA011237, 1405USA013601, 1405USA013602, 1405USA013603, 1405USA013604, 1405USA013605, 1405USA013606, 1405USA013607, 1405USA013608 and 1405USA013609).
This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Patient received doses after its beyond use date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis.     No Medical History information was reported.  On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Patient received doses after its beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received doses after its beyond use date), PRODUCT STORAGE ERROR (Patient received doses after its beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.
Pt exp sz w/fever taken to ER; LP & other labs were negative Mom reports; no infect found @ that moment; Dx febrile seizure;
This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a adult female patient who received SHINGRIX for prophylaxis. Co-suspect products included SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX and the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX and SHINGRIX, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash, influenza-like symptoms and influenza-like symptoms. On an unknown date, the outcome of the vaccination failure, shingles, rash, influenza-like symptoms and influenza-like symptoms were unknown. It was unknown if the reporter considered the vaccination failure, shingles and influenza-like symptoms to be related to SHINGRIX. It was unknown if the reporter considered the vaccination failure, shingles, rash and influenza-like symptoms to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported however it could be 73 or 74 days. The healthcare professional (HCP) reported that the patient experienced red on breast, almost like shingles coming. The HCP also reported patient experienced flu like symptoms. The symptoms were worse after second dose as compared to 1st dose. This case was considered as suspected vaccination failure as time to onset for the event was unknown. This case has been linked to the US2018169160, reported by the same reporter.
The patient complained of trouble breathing and her heart racing within 5 minutes of receiving the vaccine.  She began convulsing and gasping for breath. An epipen was administered and did not seem to help. A few minutes later we administered a second epipen. We did not administer benadryl because we were afraid she would aspirate on it.  The paramedics arrived shortly after the second epipen and took her to the emergency room.
Soreness starting the night of vaccination, could not move arm the day after vaccination. Could not move arm for 2-3 days. Pain in the arm the whole time, could not tolerate touch to arm.
Wednesday received vaccine. Thursday right arm broke out in rash that was itchy. Friday morning rash spread to left arm, both upper legs. Friday night took 50mg Benadryl. Saturday rash continued to grow to include back and abdomen, 200mg Benadryl taken that day. Sunday rash was still present, spreading to both lower legs.
burning pain in shoulders, neck, face-1 side of face swollen, lasted 24 hours
Rapid, pounding heartbeat with in 1 hour of vaccine administration, lasting 7 or more hours.
Vaccine was placed in refrigerator on 29-Oct-2021 and was administered on 3-Nov-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 29-Oct-2021 and was administered on 3-Nov-2021) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 29-Oct-2021 and was administered on 3-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 29-Oct-2021 and was administered on 3-Nov-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No adverse events reported. No temperature excursion of the product was reported. It was reported that vaccine was placed in refrigerator on 29-Oct-2021  No treatment medications were reported.
Information has been received from a registered nurse concerning an 11-year-old male with no pertinent medical history or allergies, who on 27-JUL-2007 was vaccinated subcutaneously in the right arm with a second dose of 0.5 milliliter's of varicella virus vaccine live (Oka/Merck) (lot# 657455/0599U). There was no concomitant medication. On 10-AUG-2007, the patient developed as rash all over his body. Unspecified medical attention was sought. No laboratory or diagnostic tests were performed. The outcome was reported as recovering. No product quality complaint was involved. Follow-up information was received concerning a male student with no pre-existing allergies, birth defects or medical conditions, who was vaccinated at 9 AM with a second dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccination included an intramuscular first dose in the left deltoid of Adacel (lot # PMCC2609AA) (Sanofi Pasteur) at  9 AM. There was no illness at the time of vaccination. On 09-Aug-2007, (previously reported as 10-AUG-2007) at 8 AM, the patient developed a light rash on his abdomen and trunk area. There was no fever. The rash was slightly raised and non-puritic. The patient was advised to stay out of school until the rash was cleared. The outcome was reported as recovered and the patient returned to school on 18-Aug-2007. Additional vaccinations received includes a dose of diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (manufacturer unknown) on 12-Jan-1996, 22-Mar-1996, 13-May-1996, 04-Mar-1997 and 03-Apr-2000; a dose of hepatitis B virus vaccine (unspecified) (manufacturer unknown) on 12-Jan-1996, 22-Mar-1996 and 16-Jul-1996; a dose of Hib conj vaccine (unspecified carrier) (manufacturer unknown) on 12-Jan-1996, 22-Mar-1996, 13-May-1996 and 01-Nov-1996; a dose of poliovirus vaccine inactivated (unspecified) (manufacturer unknown) on 03-Apr-2000; a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (HPV-77) (manufacturer unknown) on 01-Nov-1996, and 03-Apr-2000; and a dose of poliovirus vaccine live oral (manufacturer unknown) on 12-Jan-1996, 22-Mar-1996, 13-May-1996. Additional information is not expected.
pt recv vax;vomited,fever of 102;apap given & T dec to 101;legs sore at inject site;
VACCINATION WAS EXPIRED AT THE TIME OF ADMINISTRATION TO PATIENT;  NO IMMEDIATE REACTION WAS WITNESSED AT TIME OF ADMINISTRATION.
Received Pneumovax and flu shot (injectable) on 9/20/2013 morning. That evening started to develop generalized body aches, chills, and low grade fever. Continued for 3 days. On 9/23/2013 started to have pain in the right upper arm (both vaccines were given in this arm). Pain worsened, started to notice swelling in the upper portion of arm above elbow and three distinct reddish circles on the inner aspect of the arm just above elbow. The reddish circles seemed to grow over time. Came to clinic 9/24 for evaluation. At that time right arm was warm to the touch and swollen from approx shoulder to elbow. Very tender to touch this entire portion of the arm. Had three separate reddish maculopapular lesions approximately quarter sized on anterior surface of arm just proximal to the antecubital fossa. No signs of cellulitis. CK checked given degree of pain/muscle tenderness and was normal. Given Benadryl for potential hives + ibuprofen/Tylenol for pain + icing of the arm. Gradually improving per RN check on pt 9/25 and 9/26. Still with mild rash and now new bluish area on the upper arm near elbow (has not come for further evaluation). Fevers have resolved, pain slowly improving.
Vaccine was given 9/28/2019. Patient reported to pharmacy 11/16/19 that he had limited range of motion in shoulder. He did not give a specific start date of the problem. He stated has been working with physical therapist and his family doctor and they both agreed the problem is from the flu shot and he has had no previous problems with his shoulder.
Patient came in for his first pediatric covid vaccine which we gave to him.  Later it was discovered that an insufficient amount of diluent was added to the vial making the dose more concentrated than what was intended.  We contacted the manufacturer and reached out to the parent of this child to check on his well-being and explain the incident.  His mom  said he was doing fine and the only adverse reaction that he had was a sore arm for 2 days  which had now subsided.
Pt recvd pneumococcal vax & devel a local reaction which consisted of cellulitis & swelling of the entire arm; Pt recvd an inject of cortisone & w/in 3 to 4 days the sx subsided; no further details were provided;
Fever 104F, nasal congestion. Hospitaliced SCIU @ Hospital. CBC (normal),BMP,CXR(normal),UA(normal), Spinal tad done. Treated Ceftrioxone, IV ampicillin, IV cefotaxime and IV fluids. Afebrile while admitted, normal feeding, no vomiting. diagnosed aseptic meningitis 8/2/07-records received for DOS 5/2-5/8/07- DC DX: Aseptic meningitis. Chief complaint: fever 104, nasal congestion. Lethargic, weak. No vomiting.